Clinical trial · Interventional
Efficacy of AirGLovE in Difficult Venous Access
Assessment by Ultrasound of the Degree of Venous Dilation, Comparison Between Venodilation by Airglove (TM) Versus Warm-water Immersion (WWI)
NCT05127668CI-TRIAL-00055139EAGLEcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To determine whether Airglove™ warming device dilates upper limb veins to the same degree as the warm water immersion (WWI) method.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Airglove (TM) | Device | — | UNRESOLVED |
| Warm-water Immersion | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Airglove arm
- description
- Participants on the airglove arm were subjected to warming of their forearms using the Airglove device at 38.5oC.
- interventionNames
- Device: Airglove (TM)
- type
- EXPERIMENTAL
- label
- Warm-water Immersion arm
- description
- Participants on the WWI arm were subjected to warming by immersing their forearms into a bucket of warm water at 38.5oC.
- interventionNames
- Device: Warm-water Immersion
Primary outcomes (1)
- measure
- Name of Measurement: Change in measurement of vein diameter by ultrasound
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Participants \> 18 years old * Able to give written informed consent * Able to understand and complete questionnaire forms independently Exclusion Criteria: * Participants \< 18 years old * Participants with cancer and/or undergoing chemotherapy * Participants with difficult to cannulate veins (DTCV) * Participants with lymphoedema in either hand * Participants with pre-existing Raynaud's disease * Participants with Diabetes (Type 1 \& 2) * Participants with generalised anxiety disorder * Participants with diagnosis of hypertension * Participants with any cardiovascular disease, previous stroke, episodes of DVT, recent treatment for venous thromboembolism (VTE), recently administered heparin, participants on warfarin or any anticoagulant treatment (including NOACs). * Participants not able to give written informed consent * Participants not able to comprehend or complete questionnaire forms independently
References
Publications (0)
Data not yet available
No reference posted for this study.